BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 34648917)

  • 1. Everolimus accelerates Erastin and RSL3-induced ferroptosis in renal cell carcinoma.
    Yangyun W; Guowei S; Shufen S; Jie Y; Rui Y; Yu R
    Gene; 2022 Jan; 809():145992. PubMed ID: 34648917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer.
    Ghoochani A; Hsu EC; Aslan M; Rice MA; Nguyen HM; Brooks JD; Corey E; Paulmurugan R; Stoyanova T
    Cancer Res; 2021 Mar; 81(6):1583-1594. PubMed ID: 33483372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis.
    Imai H; Matsuoka M; Kumagai T; Sakamoto T; Koumura T
    Curr Top Microbiol Immunol; 2017; 403():143-170. PubMed ID: 28204974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RSL3 and Erastin differentially regulate redox signaling to promote Smac mimetic-induced cell death.
    Dächert J; Schoeneberger H; Rohde K; Fulda S
    Oncotarget; 2016 Sep; 7(39):63779-63792. PubMed ID: 27588473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NCOA4-mediated ferritinophagy promotes ferroptosis induced by erastin, but not by RSL3 in HeLa cells.
    Gryzik M; Asperti M; Denardo A; Arosio P; Poli M
    Biochim Biophys Acta Mol Cell Res; 2021 Feb; 1868(2):118913. PubMed ID: 33245979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines.
    Codenotti S; Poli M; Asperti M; Zizioli D; Marampon F; Fanzani A
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1717-1730. PubMed ID: 29971532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3.
    Shintoku R; Takigawa Y; Yamada K; Kubota C; Yoshimoto Y; Takeuchi T; Koshiishi I; Torii S
    Cancer Sci; 2017 Nov; 108(11):2187-2194. PubMed ID: 28837253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of SRSF9 enhances the sensitivity of colorectal cancer to erastin-induced ferroptosis by reducing glutathione peroxidase 4 expression.
    Wang R; Su Q; Yin H; Wu D; Lv C; Yan Z
    Int J Biochem Cell Biol; 2021 May; 134():105948. PubMed ID: 33609745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of the glutathione peroxidase GPx4 by the ferroptosis-inducing molecule RSL3 requires the adaptor protein 14-3-3ε.
    Vučković AM; Bosello Travain V; Bordin L; Cozza G; Miotto G; Rossetto M; Toppo S; Venerando R; Zaccarin M; Maiorino M; Ursini F; Roveri A
    FEBS Lett; 2020 Feb; 594(4):611-624. PubMed ID: 31581313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential cell death decisions in the testis: evidence for an exclusive window of ferroptosis in round spermatids.
    Bromfield EG; Walters JLH; Cafe SL; Bernstein IR; Stanger SJ; Anderson AL; Aitken RJ; McLaughlin EA; Dun MD; Gadella BM; Nixon B
    Mol Hum Reprod; 2019 May; 25(5):241-256. PubMed ID: 30865280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of GPX4 drives ferroptosis resistance in scleroderma skin fibroblasts.
    Zhang F; Xiao Y; Huang Z; Wang Y; Wan W; Zou H; Wang B; Qiu X; Yang X
    Free Radic Biol Med; 2024 Aug; 221():23-30. PubMed ID: 38740100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes.
    Baba Y; Higa JK; Shimada BK; Horiuchi KM; Suhara T; Kobayashi M; Woo JD; Aoyagi H; Marh KS; Kitaoka H; Matsui T
    Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H659-H668. PubMed ID: 29127238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutic roles of MC-4 in combination with everolimus against advanced renal cell carcinoma by dual targeting of Akt/pyruvate kinase muscle isozyme M2 and mechanistic target of rapamycin complex 1 pathways.
    Son JY; Yoon S; Tae IH; Park YJ; De U; Jeon Y; Park YJ; Rhyu IJ; Lee BM; Chung KH; Lim JE; Lee SJ; Lee HW; Kwak JH; Kim HS; Choi HY
    Cancer Med; 2018 Oct; 7(10):5083-5095. PubMed ID: 30160042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT3 deficiency is resistant to autophagy-dependent ferroptosis by inhibiting the AMPK/mTOR pathway and promoting GPX4 levels.
    Han D; Jiang L; Gu X; Huang S; Pang J; Wu Y; Yin J; Wang J
    J Cell Physiol; 2020 Nov; 235(11):8839-8851. PubMed ID: 32329068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis inducer erastin downregulates androgen receptor and its splice variants in castration‑resistant prostate cancer.
    Yang Y; Liu T; Hu C; Xia H; Liu W; Chen J; Wu S; Jiang Y; Xu Y; Liu W; Zhao L
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D; Kim EH; Lee J; Roh JL
    Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative neoadjuvant targeted therapy remodels intra-tumoral heterogeneity of clear-cell renal cell carcinoma and ferroptosis inhibition induces resistance progression.
    Chen WJ; Pan XW; Song X; Liu ZC; Xu D; Chen JX; Dong KQ; Di SC; Ye JQ; Gan SS; Wang LH; Zhou W; Cui XG
    Cancer Lett; 2024 Jul; 593():216963. PubMed ID: 38768682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Microenvironment-Responsive Nanodrug for Clear-Cell Renal Cell Carcinoma Therapy via Triggering Waterfall-Like Cascade Ferroptosis.
    Ni W; Li Y; Liang L; Yang S; Zhan M; Lu C; Lu L; Wen L
    J Biomed Nanotechnol; 2022 Feb; 18(2):327-342. PubMed ID: 35484753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase Ib study of combined VEGFR and mTOR inhibition with vatalanib and everolimus in patients with advanced renal cell carcinoma.
    Bitting RL; Healy P; Creel PA; Turnbull J; Morris K; Wood SY; Hurwitz HI; Starr MD; Nixon AB; Armstrong AJ; George DJ
    Clin Genitourin Cancer; 2014 Aug; 12(4):241-50. PubMed ID: 24685058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of tumor growth and angiogenesis underlies the enhanced antitumor activity of lenvatinib in combination with everolimus.
    Matsuki M; Adachi Y; Ozawa Y; Kimura T; Hoshi T; Okamoto K; Tohyama O; Mitsuhashi K; Yamaguchi A; Matsui J; Funahashi Y
    Cancer Sci; 2017 Apr; 108(4):763-771. PubMed ID: 28107584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.